Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
Open accessThe DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
There is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel electrophoresis. Tissue samples were obtained from 35 individuals with schizophrenia, 35 with bipolar disorder and 35 controls. Eleven protein spots in schizophrenia and 48 in bipolar disorder were found to be differentially expressed (P<0.01) in comparison to controls, with 7 additional spots found to be altered in both diseases. Using mass spectrometry, 15 schizophrenia-associated proteins and 51 bipolar disorder-associated proteins were identified. The functional groups most affected included synaptic proteins (7 of the 15) in schizophrenia and metabolic or mitochondrial-associated proteins (25 of the 51) in bipolar disorder. Six of seven synaptic-associated proteins abnormally expressed in bipolar disorder were isoforms of the septin family, while two septin protein spots were also significantly differentially expressed in schizophrenia. This finding represented the largest number of abnormalities from one protein family. All septin protein spots were upregulated in disease in comparison to controls. This study provides further characterization of the synaptic pathology present in schizophrenia and of the metabolic dysfunction observed in bipolar disorder. In addition, our study has provided strong evidence implicating the septin protein family of proteins in psychiatric disorders for the first time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteomic analysis of SZ DLPFC samples identified 15 differentially expressed proteins, 7 of which were synaptic 164.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [164]
Citations
Cites
High resolution two-dimensional electrophoresis of proteins.
O'Farrell, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41496-8 · Cited by 19,246 · cited 1×
“5 ml Eppendorf tubes with 1 ml of solubilization buffer, a lysis buffer based on that originally used by O’Farrell”
MethodCorrelation between Protein and mRNA Abundance in Yeast
Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1720 · Cited by 3,819
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The dynamin superfamily: universal membrane tubulation and fission molecules?
Praefcke, G. J. K., & McMahon, H. T. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1313 · Cited by 1,377 · cited 1×
“0055) and is localized to presynaptic nerve terminals in the brain”
BackgroundPantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
A comparison of selected mRNA and protein abundances in human liver
Anderson, L., & Seilhamer, J. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150180333 · Cited by 1,262 · cited 1×
“27 However, mRNA may not be the most reliable method to use in order to gain insight into the underlying pathophysiology of schizophrenia, where abnormalities in gene function may or may not affect downstream protein expression”
MethodProteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024 · cited 1×
“2, parts of which are deleted in velo–cardio–facial syndrome and whose sufferers have been found to have a much higher rate of schizophrenia than the general population (30p)”
Background
Research works printed but not linked: 4
- Eastwood SL, Burnet PW, Harrison PJ . Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 2005; 57: 702–710. · DOI
- Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 2005; 62: 263–272. · DOI · Paper page
- Owen MJ, O’Donovan MC, Harrison PJ . Schizophrenia: a genetic disorder of the synapse? BMJ 2005; 330: 158–159. · DOI · Paper page
- Frankle WG, Lerma J, Laruelle M . The synaptic hypothesis of schizophrenia. Neuron 2003; 39: 205–216. · DOI · Paper page
Cited by
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399
“…et al., 2005; Karry et al., 2004; Klushnik et al., 1991; Konradi et al., 2004; MacDonald et al., 2006; Middleton et al., 2002; Mill et al., 2008; Pennington et al., 2008; Washizuka et al., 2005, 2009), and linkage analysis showed an association of both disorders with genes involved in…”
BackgroundThe dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
“…is particularly harmful in patients with schizophrenia, who show an elevated oxidative stress (Minutolo et al., 2012), high levels of pro-inflammatory cytokines and several metabolic abnormalities, also at the onset of the illness (Mondelli et al., 2011; Pennington et al., 2008; Ryan et al., 2003).”
BackgroundSelf-citationPrefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Neurofilaments: neurobiological foundations for biomarker applications
Gafson, A. R., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J.-P., Kuhle, J., Leppert, D., Nixon, R. A., Weller, R. O., et al. (2020) · Brain · doi:10.1093/brain/awaa098 · Cited by 325
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“Proteomic analysis of SZ DLPFC samples identi fi ed 15 differentially expressed proteins, 7 of which were synaptic [164].”
BackgroundThe pig as an animal model for human pathologies: A proteomics perspective
Bassols, A., Costa, C., Eckersall, P. D., Osada, J., Sabrià, J., & Tibau, J. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300099 · Cited by 254
“2DE proteomic approaches have been also undertaken for schizophrenia and bipolarity [165] and anxiety disorders [166], revealing changes in proteins involved in neurotransmission (as septins), energy metabolism (metabolic or mitochondrial-associated proteins) and oxidative stress-related networks.”
BackgroundJames, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., Hubanks, A., & Gaylor, D. W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26615 · Cited by 241
Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Maccarrone, G., Dias-Neto, E., & Turck, C. W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0847-2 · Cited by 203
“A few proteome studies were performed in distinct brain regions such as anterior cingulate cortex and the corpus callosum [13, 30, 73, 75, 78, 86].”
BackgroundLe‐Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., McMahon, F. J., Schork, N. J., Nurnberger, J. I., & Niculescu, A. B. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30887 · Cited by 201
Neuroproteomics: understanding the molecular organization and complexity of the brain
Bayés, A., & Grant, S. G. N. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2701 · Cited by 186
Septin functions in organ system physiology and pathology
Dolat, L., Hu, Q., & Spiliotis, E. T. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0233 · Cited by 187
“Increases in septin 5, 6, and 11 expression were also observed in schizophrenia and bipolar disorders (Pennington et al., 2008), and SEPT9 was abnormally overexpressed in a mouse model of demyelinating neuropathy (Patzig et al.”
BackgroundMartins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi-Gulyás, E., Eberlin, M. N., Souza, G. H. M. F., Marangoni, S., Novello, J. C., Turck, C. W., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.006 · Cited by 177
Phenothiazine‐Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin‐Mediated Endocytosis
Daniel, J. A., Chau, N., Abdel‐Hamid, M. K., Hu, L., von Kleist, L., Whiting, A., Krishnan, S., Maamary, P., Joseph, S. R., Simpson, F., et al. (2015) · Traffic · doi:10.1111/tra.12272 · Cited by 166
Behan, Á., Byrne, C., Dunn, M. J., Cagney, G., & Cotter, D. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.7 · Cited by 145
“Most recently, our group undertook a proteomic analysis of the dlpf”
BackgroundSelf-citationRay, M. T., Shannon Weickert, C., & Webster, M. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.26 · Cited by 161
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia
Föcking, M., Lopez, L. M., English, J. A., Dicker, P., Wolff, A., Brindley, E., Wynne, K., Cagney, G., & Cotter, D. R. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.63 · Cited by 159
Self-citationZuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
“…on SCZ were found (Johnston-Wilson et al., 2000; Prabakaran et al., 2004; Beasley et al., 2006; Clark et al., 2006; Sivagnanasundaram et al., 2007; Pennington et al., 2008a,b; Behan et al., 2009; English et al., 2009; Martins-de-Souza et al., 2009a,b,c,d; Martins-De-Souza et al., 2010a,b; Föcking…”
BackgroundOxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155
“7) [29–68] 47 (2.”
Konradi, C., Daws, S. E., & Clay, H. B. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.025 · Cited by 144
Savitz, J. B., Price, J. L., & Drevets, W. C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.008 · Cited by 145
Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C., Marangoni, S., Turck, C. W., & Dias-Neto, E. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-17 · Cited by 143
“Background Several studies using global gene expression and proteomics analyses in different brain regions of schizophrenia (SCZ) patients have revealed dysfunctions in synaptogenesis and neural plasticity, energy metabolism, cytoskeleton assembly and oligodendrocyte metabolism [1-13].”
2‐D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease
English, J. A., Dicker, P., Föcking, M., Dunn, M. J., & Cotter, D. R. (2009) · PROTEOMICS · doi:10.1002/pmic.200900015 · Cited by 144
“Amphiphysin II functions in regulating synaptic vesicle endocytosis and has been shown to interact with synaptic proteins PACSIN and dynamin-1, both of which we have previously found altered in the dlPFC grey matter of the same subjects [31, 51, 53].”
BackgroundMethodInfluentialSelf-citationForsyth, J. K., & Lewis, D. A. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.06.006 · Cited by 144
“Scaffold proteins such as PSD-95 stabilize the new AMPARs by trapping them in the membrane and reducing their lateral mobility.”
BackgroundInfluentialTarget Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 142
Wang, Q., Charych, E. I., Pulito, V. L., Lee, J. B., Graziane, N. M., Crozier, R. A., Revilla-Sanchez, R., Kelly, M. P., Dunlop, A. J., Murdoch, H., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.87 · Cited by 141
Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134
“Disagreement is found in the literature about the extent to which SZ and bipolar disorder manifest dysregulation of energy-metabolism proteins (34, 70, 72).”
Al Shweiki, M. R., Steinacker, P., Oeckl, P., Hengerer, B., Danek, A., Fassbender, K., Diehl-Schmid, J., Jahn, H., Anderl-Straub, S., Ludolph, A. C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.019 · Cited by 131
Ageta-Ishihara, N., Miyata, T., Ohshima, C., Watanabe, M., Sato, Y., Hamamura, Y., Higashiyama, T., Mazitschek, R., Bito, H., & Kinoshita, M. (2013) · Nature Communications · doi:10.1038/ncomms3532 · Cited by 131
The Neuroproteomics of Schizophrenia
English, J. A., Pennington, K., Dunn, M. J., & Cotter, D. R. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.031 · Cited by 127
Self-citationYuan, A., Sershen, H., Veeranna, Basavarajappa, B. S., Kumar, A., Hashim, A., Berg, M., Lee, J.-H., Sato, Y., Rao, M. V., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.45 · Cited by 127
Recent advances in quantitative neuroproteomics
Craft, G. E., Chen, A., & Nairn, A. C. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.008 · Cited by 126
Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 125
“Interestingly, a recent postmortem study concluded that protein and mRNA expression of septin 11, in addition to other septin family members, is significantly elevated in the DLPFC of both schizophrenic and bipolar cases compared to controls (Pennington et al., 2008).”
ResultNascimento, J. M., & Martins-de-Souza, D. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2014.3 · Cited by 125
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador-Woodruff, J. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.239 · Cited by 111
“One approach to get around this issue has been pooling of samples; pooled samples are assayed and help generate specific hypotheses that may be tested with smaller quantities of tissue (English et al, 2009; English et al, 2011; Pennington et al, 2008).”
BackgroundJames, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0614-2 · Cited by 115
Defects in Bioenergetic Coupling in Schizophrenia
Sullivan, C. R., O'Donovan, S. M., McCullumsmith, R. E., & Ramsey, A. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.014 · Cited by 115
Schizophrenia: a disorder of broken brain bioenergetics
Henkel, N., Wu, X., O'Donovan, S. M., Devine, E. A., Jiron, J. M., Rowland, L. M., Sarnyai, Z., Ramsey, A. J., Wen, Z., Hahn, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01494-x · Cited by 108
“The enzyme 6-phosphogluconolactonase, which produces NAPDH, the co-factor used to reduce oxidized glutathione, was increased in schizophrenia [91].”
BackgroundFöcking, M., Dicker, P., English, J. A., Schubert, K. O., Dunn, M. J., & Cotter, D. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.43 · Cited by 90
“Clathrin-mediated endocytosis is a key cellular signaling process involved in the fine-tuning of neurotransmission,(106,110-112) and we have previously demonstrated changes of protein members of the CME interactome,(106) namely amphiphysin,(46) clathrin adaptor protein complex 2,(113) protein kinase C and casein kinas…”
ResultSelf-citationSchizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
Harris, L. W., Guest, P. C., Wayland, M. T., Umrania, Y., Krishnamurthy, D., Rahmoune, H., & Bahn, S. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.009 · Cited by 104
“, 2009a) but not all (Pennington et al., 2008) proteome profiling studies of frontal cortex and in global transcriptome profiling studies (Middleton et al.”
BackgroundSchubert, K. O., Föcking, M., & Cotter, D. R. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.002 · Cited by 95
“…and statistical evaluation For both proteomic screens (pH 4-7 and pH 6-11), samples were Samples were processed and separated by 2-dimensional difference gel electrophoresis (2D-DIGE) as described previously (Behan et al., 2008; English et al., 2009; Focking et al., 2011b; Pennington et al., 2008).”
MethodSelf-citationInsights into myelin dysfunction in schizophrenia and bipolar disorder
Valdés‐Tovar, M., Rodríguez‐Ramírez, A. M., Rodríguez-Cárdenas, L., Sotelo-Ramírez, C. E., Camarena, B., Sanabrais‐Jiménez, M. A., Solís‐Chagoyán, H., Argueta, J., & López-Riquelme, G. O. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i2.264 · Cited by 104
James, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0591-5 · Cited by 107
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 101
Proteomic research in psychiatry
Taurines, R., Dudley, E., Grassl, J., Warnke, A., Gerlach, M., Coogan, A. N., & Thome, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106931 · Cited by 92
“In a further study on the dorsolateral prefrontal cortex in schizophrenia and BPD, an overlap of seven altered protein spots in 2D-PAGE appeared (Pennington et al., 2007).”
BackgroundSchubert, K. O., Föcking, M., Prehn, J. H. M., & Cotter, D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.123 · Cited by 99
Self-citationIncreased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness
Feresten, A. H., Barakauskas, V., Ypsilanti, A. R., Barr, A. M., & Beasley, C. L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.024 · Cited by 99
“Synaptic, metabolic and inflammatory dysregulation have been documented in SCZ and BPD (e.g. Pennington et al., 2008a; Drexhage et al., 2010; Rao et al., 2013), leading to speculation that astrocyte dysfunction occurs in these disorders.”
InfluentialSelf-citationProteome analysis of schizophrenia brain tissue
Martins-De-Souza, D., Dias-Neto, E., Schmitt, A., Falkai, P., Gormanns, P., Maccarrone, G., Turck, C. W., & Gattaz, W. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903490626 · Cited by 89
Cassoli, J. S., Guest, P. C., Malchow, B., Schmitt, A., Falkai, P., & Martins-de-Souza, D. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.34 · Cited by 89
Emerging evidence for astrocyte dysfunction in schizophrenia
Figueiredo, E. C. D. O., Calì, C., Petrelli, F., & Bezzi, P. (2022) · Glia · doi:10.1002/glia.24221 · Cited by 92
“…2021) and further studies show a decrease of factors and enzymes involved in the production of energy (i.e., adenosine triphosphate–ATP-generation and storage) (Iwamoto et al., 2005; Karry et al., 2004; Klushnik et al., 1991; Middleton et al., 2002; Pennington et al., 2008; Washizuka et al., 2009).”
BackgroundSpecialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders
Yuan, A., & Nixon, R. A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.09.002 · Cited by 85
“NFL transcripts are reported significantly reduced, along with NFM and alpha-internexin proteins [135], in adults with bipolar disorder (mean age 42y), but not in major depressive disorder [41].”
Chan, M. K., Tsang, T. M., Harris, L. W., Guest, P. C., Holmes, E. C., & Bahn, S. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.100 · Cited by 94
Proteomics Research in Schizophrenia
Davalieva, K., Kostovska, I. M., & Dwork, A. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00018 · Cited by 91
“D PAGE/MS (Sivagnanasundaram et al., 2007), and LC-MS (Saia-Cereda et al., 2015), respectively.”
BackgroundInfluentialPruett, B. S., & Meador‐Woodruff, J. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.003 · Cited by 88
Niu, M., Wang, Y., Jia, Y., Wang, J., Zhong, S., Lin, J., Sun, Y., Zhao, L., Liu, X., Huang, L., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.010 · Cited by 82
“Such changes are consistentwith aberrant DLPFC gene expression in patients with BD (Pennington et al., 2008; Shao & Vawter, 2008).”
BackgroundProteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia
Martins-de-Souza, D. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.007 · Cited by 81
McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.035 · Cited by 87
Patel, S. D., Le‐Niculescu, H., Koller, D. L., Green, S. D., Lahiri, D. K., McMahon, F. J., Nurnberger, J. I., & Niculescu, A. B. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31087 · Cited by 74
Septin 14 Is Involved in Cortical Neuronal Migration via Interaction with Septin 4
Shinoda, T., Ito, H., Sudo, K., Iwamoto, I., Morishita, R., & Nagata, K.-I. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0869 · Cited by 74
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets
Li, Y. C., & Kavalali, E. T. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013342 · Cited by 81
“Altered dynamin expression has also been detected in schizophrenia patients (Pennington et al., 2008; Focking et al., 2011; Cottrell et al., 2013).”
BackgroundSullivan, C. R., Koene, R., Hasselfeld, K., O'Donovan, S. M., Ramsey, A. J., & McCullumsmith, R. E. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0035-3 · Cited by 81
“Microarray studies found significant decreases in expression of genes encoding proteins involving the malate shuttle, tricarboxylic acid (TCA) cycle, as well as the ornithine– polyamine, aspartate–alanine, and ubiquitin metabolism groups in the dorsolateral prefrontal cortex (DLPFC)(1-13).”
BackgroundProteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia
Pennington, K., Dicker, P., Dunn, M. J., & Cotter, D. R. (2008) · PROTEOMICS · doi:10.1002/pmic.200800415 · Cited by 73
“Subsequently, strips were equilibrated as described previously [30].”
BackgroundMethodResultInfluentialSelf-citationAltered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide
Kékesi, K. A., Juhász, G., Simor, A., Gulyássy, P., Szegő, É. M., Hunyadi-Gulyás, É., Darula, Z., Medzihradszky, K. F., Palkovits, M., Penke, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050532 · Cited by 72
“*+SEPT5 [119], [122] Septin 5 qq Q99648 Plasma membrane, septin complex, synaptic vesicle Cell cycle, regulation of exocytosis”
BackgroundSaia-Cereda, V. M., Cassoli, J. S., Schmitt, A., Falkai, P., Nascimento, J. M., & Martins‐de‐Souza, D. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0621-1 · Cited by 77
“20 08 [ 62 ]; 7 B eh an e t al .”
To label or not to label: Applications of quantitative proteomics in neuroscience research
Filiou, M. D., Martins‐de‐Souza, D., Guest, P. C., Bahn, S., & Turck, C. W. (2012) · PROTEOMICS · doi:10.1002/pmic.201100350 · Cited by 73
Heurich, M., Föcking, M., Mongan, D., Cagney, G., & Cotter, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01197-9 · Cited by 73
Self-citationQuantitative proteomics for investigating psychiatric disorders
Filiou, M. D., Turck, C. W., & Martins‐de‐Souza, D. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000060 · Cited by 69
Characterization of presynaptic septin complexes in mammalian hippocampal neurons
Tsang, C. W., Estey, M. P., DiCiccio, J. E., Xie, H., Patterson, D., & Trimble, W. S. (2011) · Biological Chemistry · doi:10.1515/bc.2011.077 · Cited by 68
Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia
Gibbons, A. S., Udawela, M., & Dean, B. (2018) · Non-Coding RNA · doi:10.3390/ncrna4020011 · Cited by 72
Föcking, M., Dicker, P., Lopez, L. M., Hryniewiecka, M., Wynne, K., English, J. A., Cagney, G., & Cotter, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.224 · Cited by 59
Self-citationA New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue
Elsayed, M., & Magistretti, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00468 · Cited by 59
“, 2008) or increased expression (Pennington et al., 2008; Feresten et al., 2013).”
BackgroundTopol, A., English, J. A., Flaherty, E. K., Rajarajan, P., Hartley, B. J., Gupta, S., Desland, F. A., Zhu, S., Goff, T., Friedman, L., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.118 · Cited by 59
Self-citationBarakauskas, V., Beasley, C. L., Barr, A. M., Ypsilanti, A. R., Li, H., Thornton, A. E., Wong, H., Rosokilja, G., Mann, J. J., Mancevski, B., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.228 · Cited by 59
Self-citationGuest, P. C., Iwata, K., Kato, T. A., Steiner, J., Schmitt, A., Turck, C. W., & Martins-de-Souza, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00180 · Cited by 53
“…et al., 2009, 2011; Martins-de-Souza et al., 2011a), neuronal structure and transport (Carlino et al., 2011; Chan et al., 2011; English et al., 2011), and cell trafficking and signal transduction (Pennington et al., 2008; English et al., 2011; Föcking et al., 2011;Martins-de-Souza et al., 2011a).”
BackgroundSmalla, K., Mikhaylova, M., Sahin, J., Hg, B., Bogerts, B., Schmitt, A., van der Schors, R. C., Smit, A. B., Li, K. W., Gundelfinger, E. D., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.60 · Cited by 56
Psychiatric disorders biochemical pathways unraveled by human brain proteomics
Saia-Cereda, V. M., Cassoli, J. S., Martins‐de‐Souza, D., & Nascimento, J. M. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0709-2 · Cited by 57
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry
Lozupone, M., Seripa, D., Stella, E., Montagna, M. L., Solfrizzi, V., Quaranta, N. A. A., Veneziani, F., Cester, A., Sardone, R., Bonfiglio, C., et al. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1375857 · Cited by 56
“In BD patients, MS analysis of the dorsolateral prefrontal cortex (DLPFC) pinpointed changes in cell metabolism, signaling cascades, regulation of gene transcription, protein and RNA chaperoning functional groups [70,71].”
BackgroundSong, Y., Wu, B. C., Yang, Y., Chen, J., Zhang, L. J., Zhang, Z. W., Shi, H., Huang, C., Pan, J., & Xie, P. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154550 · Cited by 51
Martins‐de‐Souza, D., Cassoli, J. S., Nascimento, J. M., Hensley, K., Guest, P. C., Velasco, A. M. P., & Turck, C. W. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500004 · Cited by 51
Le-Niculescu, H., Case, N. J., Hulvershorn, L., Patel, S. D., Bowker, D., Gupta, J., Bell, R., Edenberg, H. J., Tsuang, M. T., Kuczenski, R., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.1 · Cited by 48
Altered Complexin Expression in Psychiatric and Neurological Disorders: Cause or Consequence?
Brose, N. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17545-5 · Cited by 47
van Beveren, N. J. M., Schwarz, E., Noll, R., Guest, P. C., Meijer, C. J., de Haan, L., & Bahn, S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.52 · Cited by 45
PACSIN proteins in vivo: Roles in development and physiology
Dumont, V., & Lehtonen, S. H. (2022) · Acta Physiologica · doi:10.1111/apha.13783 · Cited by 47
O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Zammit, S., Lewis, G., Roche, H. M., Mattila, I. M., Hyötyläinen, T., Orešič, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.211 · Cited by 47
Self-citationKim, Y., Zhang, Y., Pang, K., Kang, H., Park, H., Lee, Y., Lee, B., Lee, H., Kim, W.-K., Geum, D., et al. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.6.296 · Cited by 45
“In addition to the genetic association, altered expression of synaptic proteins, and abnormalities in synaptic morphology and function have been observed in postmortem human brains and animal models of BD [7-10].”
BackgroundAnterior Hippocampus in Schizophrenia Pathogenesis: Molecular Evidence from a Proteome Study
Nesvaderani, M., Matsumoto, I., & Sivagnanasundaram, S. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902721103 · Cited by 44
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Amato, D., Beasley, C. L., Hahn, M., & Vernon, A. C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.004 · Cited by 47
Self-citationShi, X., Kondo, D. G., Sung, Y., Hellem, T., Fiedler, K. K., Jeong, E., Huber, R. S., & Renshaw, P. F. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01040.x · Cited by 43
“Converging lines of evidence implicate mitochondrial dysfunction in the pathophysiology of BD (12), including molecular (13–15), family-based (16–19), expression analysis (20–22), proteomic (23), in vitro (24–26), cerebrospinal fluid (CSF) (27, 28), post-mortem(29–31), and animal studies (32–35).”
BackgroundPires, G., McElligott, S., Drusinsky, S., Halliday, G., Potier, M.-C., Wisniewski, T., & Drummond, E. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0848-6 · Cited by 39
Farrelly, L., Föcking, M., Piontkewitz, Y., Dicker, P., English, J., Wynne, K., Cannon, M., Cagney, G., & Cotter, D. R. (2015) · Developmental Neuroscience · doi:10.1159/000368305 · Cited by 38
Self-citationDysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
He, J.-G., Zhou, H.-Y., Wang, F., & Chen, J.-G. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.02.007 · Cited by 36
“Patients with schizophrenia or bipolar disorder display reduced levels of syndapin-1 protein in the dorsolateral PFC (86,87).”
BackgroundAkula, N., Wendland, J. R., Choi, K. H., & McMahon, F. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.218 · Cited by 38
“…prior studies that have implicated the PSD in BD and other neuropsychiatric disorders (el-Mallakh and Wyatt, 1995; Kristiansen and Meador-Woodruff, 2005; Beneyto and Meador-Woodruff, 2008; Pennington et al, 2008; Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium, 2015).”
BackgroundMass spectrometry for the detection of potential psychiatric biomarkers
Wetie, A. G. N., Sokolowska, I., Wormwood, K. L., Beglinger, K. M., Michel, T. M., Thome, J., Darie, C. C., & Woods, A. G. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-8 · Cited by 37
“Though genomics was originally the state of the art discipline for psychiatric biomarker discovery; one can notice the shift that has been taking place in the last decade from genomics- to proteomics-based techniques [26,83-91].”
BackgroundKlaus, K., Butler, K., Durrant, S. J., Ali, M., Inglehearn, C. F., Hodgson, T. L., Gutiérrez, H., & Pennington, K. (2017) · Brain and Behavior · doi:10.1002/brb3.695 · Cited by 38
“Understanding how certain genetic vulnerabilities might affect or impair cognitive processes mediated by the prefrontal cortex (PFC) is of great importance given the functional abnormalities of the PFC present in schizophrenia and bipolar disorder (Pennington et al., 2008).”
BackgroundSelf-citationAgeta‐Ishihara, N., Yamakado, H., Morita, T., Hattori, S., Takao, K., Miyakawa, T., Takahashi, R., & Kinoshita, M. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-35 · Cited by 38
“; licensee BioMed Creative Commons Attribution License (http:/ distribution, and reproduction in any medium dorsolateral prefrontal cortices [1] and scarcity of SEPT11 in the hippocampal CA2/3 regions [2].”
BackgroundPiubelli, C., Vighini, M., Mathé, A. A., Domenici, E., & Carboni, L. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001306 · Cited by 35
“Several members of this protein family showed a dysregulation in the dorsolateral prefrontal cortex of bipolar disorder and schizophrenia patients (Pennington et al. 2008), indicating an important role for this class of proteins in the pathophysiology of psychiatric disorders.”
BackgroundCorena-McLeod, M. D. P., Walss‐Bass, C., Oliveros, A., Villegas, A. G., Ceballos, C., Charlesworth, C. M., Madden, B. J., Linser, P. J., Ekeris, L. V., Smith, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052147 · Cited by 37
Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia
Pinacho, R., Villalmanzo, N., Meana, J. J., Ferrer, I., Berengueras, A., Haro, J. M., Villén, J., & Ramos, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.050 · Cited by 35
“…Chan et al., 2011; English et al., 2009; English et al., 2011; Johnston-Wilson et al., 2000; Martins-de-Souza et al., 2009a; Martins-de-Souza et al., 2009b; Novikova et al., 2006; Pennington et al., 2008; Prabakaran et al., 2004; Smalla et al., 2008; Wesseling et al., 2013) (Supplementary Data 2).”
BackgroundResultFiliou, M. D., & Turck, C. W. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00001-8 · Cited by 39
“Similar to the aforementioned studies in animal models, data generated from a number of proteomic studies on human brain tissue have implicated energy metabolism alterations and synaptic pathology in schizophrenia, bipolar, and anxiety disorders (Beasley et al., 2006; Clark et al., 2006; Filiou et al., 2011b; Johnston…”
BackgroundResultProteomic technologies for biomarker studies in psychiatry: advances and needs.
Martins-de-Souza, D., Guest, P., Vanattou-Saifoudine, N., Harris, L., & Bahn, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00004-3 · Cited by 31
Metadata
- Authors
- Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R.
- Affiliations
- Royal College of Surgeons in Ireland (IE)
- University of British Columbia (CA)
- University College Dublin (IE)
- King's College London (GB)
- Imperial College London (GB)
- Corresponding author
- Cotter, D R
- Venue
- Molecular Psychiatry
- Published
- 2007-10-16
- Volume
- 13
- Issue
- 12
- Pages
- 1102-1117
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2084002557
- Cited by
- 227
- References
- 95
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 14 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 14 · 2012: 11
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lincoln Repository (University of Lincoln) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, bipolar disorder, dorsolateral prefrontal cortex, synaptic proteins, mitochondrial proteins, metabolic dysfunction, differentially expressed proteins, mental illness
- MeSH terms
- Adult, Analysis of Variance, Bipolar Disorder, Chromatography, Liquid, Female, Humans, Male, Middle Aged, Schizophrenia, Electrophoresis, Gel, Two-Dimensional, Case-Control Studies, Databases, Factual, Prefrontal Cortex, Proteomics, Intracellular Signaling Peptides and Proteins, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.